|
68Ga-PSMA-11 Clinical Trials
4 actively recruiting trials across 2 locations
▼ -1 trial since July 2026
Also known as: 68Ga-PSMA-11 injection, 68Ga-PSMA-HBED-CC, Gallium Ga 68 Gozetotide, Illuccix, Illucix +1 more
Pipeline
Phase 1: 1Phase 3: 1Phase 2/3: 1
Top Sponsors
- Weill Medical College of Cornell University1
- Telix Pharmaceuticals (Innovations) Pty Limited1
- Peking Union Medical College Hospital1
- First Affiliated Hospital of Fujian Medical University1
Indications
- Cancer4
- Prostate Cancer3
- Carcinoma of the Prostate1
- Prostate Biopsy1
- Elevated PSA1
Other2 trials
Los Angeles, California1 trial
PSMA PET Combined With MRI for the Detection of PCa
University of California Los Angeles
Phase 3
Brooklyn, New York1 trial
Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer
Brooklyn Methodist Hospital - New York Presbyterian
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.